Immunomonitoring core facilities
Design, validate or accelerate clinical development with expert infrastructures.
Offer overview
What this offer helps you achieve
Design, validate or accelerate clinical development with expert infrastructures.
Scientific and technical scope
Immunomonitoring core facilities network offers high-throughput assays and the most innovative tests for characterizing the immune response (early detection of immunotoxicity or cytokine release syndrome), to follow up or predict CART cell persistence, or chimerism in the context of HSC allografts or validate predictive biomarker of clinical response to vaccine or cancer immunotherapy. Pr Eric Tartour DOI: 10.1136/jitc-2024-009440 Pr Olivier Lambotte Pr Marie Hélène Delfau Larue Dr Michelle Rosenzwajg Pr Guy Georges Gorochov Pr Guislaine CARCELAIN Pr Sophie Caillat Zuckman Pr Vahid Asnafi
Capabilities mobilised
BiomarkersClinical validationPlatforms
Application fields
Discuss this offer
Could this capability strengthen your R&D programme?
Present your scientific, technical or clinical need and identify the most relevant route to collaboration.
Continue exploring
Related expertise for your programme
Offers selected through shared capabilities, application fields or institute expertise.
